<DOC>
	<DOCNO>NCT00076531</DOCNO>
	<brief_summary>Phase III trial use injectable treatment prostate cancer .</brief_summary>
	<brief_title>Clinical Trial Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria />
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
	<keyword>PSA</keyword>
	<keyword>Leuprolide</keyword>
</DOC>